Evaluation of Diet and Exercise in Prostate Cancer Patients
NCT ID: NCT01960881
Last Updated: 2022-08-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1331 participants
OBSERVATIONAL
2013-09-19
2021-08-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Real Life Evaluation of Lupron in the Management of Prostate Cancer: A Canadian Post Marketing Observational Study
NCT01386684
Feasibility of Measuring Exercise's Effects on Molecular Mechanisms of Disease Progression in Prostate Cancer
NCT02481648
Exercise Prescription Dose for Castration Resistance Prostate Cancer Patients
NCT03526562
Living Well on Androgen Deprivation Therapy
NCT02108613
Diet and Exercise Interventions Among Men With Prostate Cancer (Prostate 8-II)
NCT03999151
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Prostate Cancer Patients
Prostate Cancer Patients
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
ii. Has provided written informed consent allowing the use of their data for the study and providing permission for contact by the study personnel.
iii. Diagnosed with PCa.
iv. Prescribed Lupron as part of his treatment by his treating physician.
Exclusion Criteria
ii. Presence of other condition that, in the opinion of the treating physician, prohibits the patient from participating in the study or obscures the assessment of the treatment of PCa.
iii. More than 6 months of therapy if currently on continuous Luteinizing hormone-releasing hormone (LHRH) treatment.
iv. If at study enrollment the intent is to only prescribe 1 dose of Lupron (leuprolide acetate)
18 Years
99 Years
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
JSS Medical Research; CMX Research Inc.; Canadian Urology Research Consortium
UNKNOWN
AbbVie
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
ABBVIE INC.
Role: STUDY_DIRECTOR
AbbVie
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Exdeo Clinical Research Inc /ID# 116040
Abbotsford, British Columbia, Canada
Southern Interior Medical Research /ID# 116025
Kelowna, British Columbia, Canada
Dr. J. Paul Whelan, Inc. /ID# 120415
Victoria, British Columbia, Canada
CancerCare Manitoba /ID# 135976
Winnipeg, Manitoba, Canada
Saint John Regional Hospital /ID# 141302
Saint John, New Brunswick, Canada
QE II Health Sciences Centre /ID# 118941
Halifax, Nova Scotia, Canada
The Male/Female Hlth and Res /ID# 116042
Barrie, Ontario, Canada
The Male/Female Hlth and Res /ID# 124295
Barrie, Ontario, Canada
Edward F.A. Woods Medicine Professional Corporation /ID# 120695
Belleville, Ontario, Canada
Jonathan Giddens Medicine /ID# 116023
Brampton, Ontario, Canada
Brantford Urology Research /ID# 116026
Brantford, Ontario, Canada
G. Kenneth Jansz Medicine Professional Corporation /ID# 116024
Burlington, Ontario, Canada
William R. Love, Medicine, Professional Corporation /ID# 116035
Burlington, Ontario, Canada
Northern Urology Centre /ID# 141391
Greater Sudbury, Ontario, Canada
St. Joseph's Healthcare /ID# 163973
Hamilton, Ontario, Canada
Queen's University /ID# 137983
Kingston, Ontario, Canada
London Health Sciences Center /ID# 118940
London, Ontario, Canada
DiCostanzo, Markham, CA /ID# 137272
Markham, Ontario, Canada
Mor Urology Inc /ID# 116027
Newmarket, Ontario, Canada
Stanley Flax Medical Prof Corp /ID# 116022
North YORK, Ontario, Canada
Fe/Male Health Centers /ID# 116020
Oakville, Ontario, Canada
The Ottawa Hospital /ID# 132329
Ottawa, Ontario, Canada
Dr. Sean Pierre Medicine Professional Corporation /ID# 137986
Ottawa, Ontario, Canada
Kawarth Urology Associates /ID# 116041
Peterborough, Ontario, Canada
The Medical Centre /ID# 128278
Peterborough, Ontario, Canada
Abara Medicine Professional Corporation /ID# 137270
Richmond Hill, Ontario, Canada
Dr. Petar Erdeljan Medicine Professional Corporation /ID# 139641
Scarborough Village, Ontario, Canada
1837206 Ontario Inc. /Id# 116038
Scarborough Village, Ontario, Canada
Urology and Male Fertility /ID# 116043
Scarborough Village, Ontario, Canada
Duplicate_Sunnybrook Health Sciences Ctr /ID# 136597
Toronto, Ontario, Canada
Princess Margaret Cancer Centre /ID# 137984
Toronto, Ontario, Canada
Toronto Urology Clin Study Grp /ID# 116044
Toronto, Ontario, Canada
Toronto West Urology Associates /ID# 116021
Toronto, Ontario, Canada
Toronto West Urology Associates /ID# 134134
Toronto, Ontario, Canada
Clinique d'urologie /ID# 116019
Chicoutimi, Quebec, Canada
CISSS - Hôpital de Gatineau /ID# 131309
Gatineau, Quebec, Canada
CISSS de la Monteregie /ID# 116036
Greenfield Park, Quebec, Canada
CISSS de la Monteregie /ID# 124296
Greenfield Park, Quebec, Canada
CISSS de la Monteregie /ID# 134137
Greenfield Park, Quebec, Canada
Clinique d'Urologie á Polyclinique Médicale Concorde /ID# 116037
Laval, Quebec, Canada
Hopital Cite-de-la-Sante /ID# 130951
Laval, Quebec, Canada
CHUM - Notre-Dame Hospital /ID# 137271
Montreal, Quebec, Canada
Montreal General Hospital - McGill University Health Center /ID# 141503
Montreal, Quebec, Canada
Jewish General Hospital /ID# 120416
Montreal, Quebec, Canada
Ultra-Med Research /ID# 116355
Pointe-Claire, Quebec, Canada
CHUS - Hopital Fleurimont /ID# 124275
Sherbrooke, Quebec, Canada
Ctr Sante et Services Sociaux /ID# 131230
Trois-Rivières, Quebec, Canada
Groupe De Recherche En Urologie De La Mauricie /ID# 116356
Trois-Rivières, Quebec, Canada
Clinique des Spécialités Chirurgicales de Val-d'Or /ID# 116039
Val-d'Or, Quebec, Canada
9120-1947 Quebec Inc. /ID# 129151
Westmount, Montreal, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
clinical study report synopsis
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P14-096
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.